[{"Assets_0_Q2_USD":"4335386000.0","CIK":"875320","CommonStockSharesIssued_0_Q2_shares":"254882837.0","CommonStockSharesOutstanding_0_Q2_shares":"254882837.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.82","EarningsPerShareBasic_2_Q2_USD":"1.65","EarningsPerShareDiluted_1_Q2_USD":"0.8","EarningsPerShareDiluted_2_Q2_USD":"1.61","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","MinorityInterest_0_Q2_USD":"28655000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"574360000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"207295000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"417460000.0","NetIncomeLoss_1_Q2_USD":"207360000.0","NetIncomeLoss_2_Q2_USD":"417623000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","ProfitLoss_1_Q2_USD":"206250000.0","ProfitLoss_2_Q2_USD":"433551000.0","RevenuesConverted_1_Q2_USD":"752157000.0","RevenuesConverted_2_Q2_USD":"1392956000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"2714883000.0","StockholdersEquity_0_Q2_USD":"2686228000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"258584000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"258557000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"254135000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"253685000.0","filed":"20180726","footnote":null,"form":"10-Q","fp":"Q2","fy":"2018.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20180630","qtrs":"0","uom":"USD"}]